3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
68
Leukemia
56
Myelodysplastic Syndromes
53
Lymphoma
47
Precursor Cell Lymphoblastic Leukemia-Lymphoma
46
Lymphoma, Non-Hodgkin
43
Multiple Myeloma
40
Hodgkin Disease
39
Leukemia, Lymphocytic, Chronic, B-Cell
35
Congenital Abnormalities
30
Lymphoma, Follicular
28
Lymphoma, Large B-Cell, Diffuse
27
Lymphoma, Mantle-Cell
26
Neoplasms, Plasma Cell
25
Lymphoma, B-Cell, Marginal Zone
24
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
23
Burkitt Lymphoma
23
Myeloproliferative Disorders
22
Lymphoma, Large-Cell, Immunoblastic
22
Leukemia, Myelomonocytic, Chronic
22
Blast Crisis
22
Leukemia, Myeloid, Chronic-Phase
21
Leukemia, Myeloid, Accelerated Phase
21
Primary Myelofibrosis
19
Lymphoma, T-Cell, Cutaneous
15
Hematologic Neoplasms
15
Graft vs Host Disease
15
Dendritic Cell Sarcoma, Interdigitating
14
Anemia, Refractory, with Excess of Blasts
14
Waldenstrom Macroglobulinemia
13
Interventions
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
LY3023414
2
sonidegib
1
sodium thiosulfate
1
ensartinib
1
cixutumumab
1
cabozantinib
1
Restraint, Physical
1
Pharmacogenomic Variants
1
MLN 8237
1
Cyproheptadine
1
Arsenic Trioxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hepatoblastoma
×
Busulfan
×
Clear all
No trials found.